Effects of methylphenidate on resting state connectivity in healthy controls and in adults with Attention Deficit Hyperactivity Disorder.
- Conditions
- ADHDAttention Deficit Hyperactivity Disorder10009841
- Registration Number
- NL-OMON39764
- Lead Sponsor
- niversitair Medisch Centrum Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Withdrawn
- Sex
- Not specified
- Target Recruitment
- 80
- Male sex
- Written informed consent
- For the ADHD group only: a diagnosis of ADHD.
- Physically healthy (according to physical screening)
- Age under 18 or over 40
- Previous or current medical, psychiatric, or neurological problems (with exception of ADHD for the ADHD group)
- Use of psychotropic medication
- Use of recreational drugs in the two weeks before start of the study
- Consuming an equivalent of >5 cups of coffee per day
- Consuming three or more alcohol units per day
- The presence of one or more of the contraindications or warnings
against the study drug as listed in the SPC
- Presence of any contraindication to MRI scanning (e.g. implanted metallic object or electronic device)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study endpoint is the difference in functional connectivity between<br /><br>participants who ingested methylphenidate and those who ingested placebo.</p><br>
- Secondary Outcome Measures
Name Time Method <p>A secondary study endpoint is the difference in functional connectivity between<br /><br>participants with ADHD and healthy controls. In addition, the correlation of<br /><br>functional network organization with both task performance (as a measure of<br /><br>cognitive performance) and blood levels of methylphenidate. Lastly, the<br /><br>correlation of whole brain cortical thickness and white matter volume with the<br /><br>main study parameters and task performance (as a measure of cognitive<br /><br>performance).</p><br>